Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGJ398 + Imatinib in Advanced GIST
NCT02257541Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2014
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of infigratinib in gastrointestinal stromal tumor (GIST), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2014; status: completed.
02
Drugs
infigratinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02257541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257541.